Descripción

Adverse event profiles from the synbiotic trial are tabulated, documenting safety and tolerability of the probiotic-prebiotic combination.

Figure 16

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 16: Adverse event profiles from the synbiotic trial are tabulated, documenting safety and tolerability of the probiotic-prebiotic combination.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)

<figure>
  <img src="" alt="Adverse event profiles from the synbiotic trial are tabulated, documenting safety and tolerability of the probiotic-prebiotic combination." />
  <figcaption>Figure 16. Adverse event profiles from the synbiotic trial are tabulated, documenting safety and tolerability of the probiotic-prebiotic combination.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Evidencia relacionada

Bifidobacterium longum para Irritable Bowel Syndrome (IBS)

Calificación B · 4 estudios

Galactooligosaccharides (GOS) para Irritable Bowel Syndrome (IBS)

Calificación B · 3 estudios

Lactobacillus acidophilus para Irritable Bowel Syndrome (IBS)

Calificación B · 3 estudios

Fructooligosaccharides (FOS) para Irritable Bowel Syndrome (IBS)

Calificación D · 2 estudios